Regenicin, Inc.: Revision history

20 August 2022

• curprev 15:1915:19, 20 August 2022 95.149.241.133 talk 723 bytes +11 No edit summary undo

13 August 2022

• curprev 23:1523:15, 13 August 2022 109.180.50.163 talk 712 bytes +15 No edit summary undo

31 July 2022

• curprev 00:2600:26, 31 July 2022 >Chris 697 bytes +697 Created page with "Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various..."